Met Life Investment Management, LLC Affimed N.V. Transaction History

Met Life Investment Management, LLC

$17.1 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 May 10, 2024	SELL	$1.1 - $2.45 $59,789 - $133,167	-54,354 Reduced 71.28%	21,900 $27,000
Q4 2022 Jun 14, 2023	BUY	$1.1 - $2.45 $24,090 - $53,655	21,900 New	21,900 $27.2 Million
Q3 2022 May 10, 2024	BUY	$1.96 - $3.32 $55,973 - $94,812	28,558 Added 59.88%	76,254 $157,000
Q3 2022 Jun 14, 2023	BUY	$1.96 - $3.32 $149,457 - $253,163	76,254 New	76,254 $157 Million
Q2 2022 May 10, 2024	SELL	$2.27 - $4.86 $21,254 - $45,504	-9,363 Reduced 16.41%	47,696 $132,000
Q2 2022 Jun 20, 2023	BUY	$2.27 - $4.86 $108,269 - $231,802	47,696 New	47,696 $132 Million
Q1 2022 May 10, 2024	BUY	$3.69 - $5.65 $210,547 - $322,383	57,059 New	57,059 $249,000
Q1 2022 Jun 20, 2023	BUY	$3.69 - $5.65 $210,547 - $322,383	57,059 New	57,059 $249 Million
Q4 2021 May 17, 2024	SELL	$5.37 - $7.07 $76,474 - $100,683	-14,241 Reduced 34.21%	27,391 $151,000
Q4 2021 Jun 21, 2023	BUY	$5.37 - $7.07 $147,089 - $193,654	27,391 New	27,391 $151 Million
Q3 2021 May 17, 2024	BUY	$5.54 - $7.51 $61,438 - $83,285	11,090 Added 36.31%	41,632 $257,000
Q3 2021 Jun 21, 2023	BUY	$5.54 - $7.51 $230,641 - $312,656	41,632 New	41,632 $257 Million
Q2 2021 May 17, 2024	SELL	$7.78 - $11.4 $111,199 - $162,940	-14,293 Reduced 31.88%	30,542 $259,000
Q1 2021 May 17, 2024	BUY	$5.12 - $8.48 $229,555 - $380,200	44,835 New	44,835 $354,000
Q1 2021 Jun 26, 2023	BUY	$5.12 - $8.48 $229,555 - $380,200	44,835 New	44,835 $355 Million
Q4 2020 May 24, 2024	BUY	$3.16 - $7.03 $35,471 - $78,911	11,225 Added 93.15%	23,276 $135,000
Q4 2020 Jun 22, 2023	BUY	$3.16 - $7.03 $73,552 - $163,630	23,276 New	23,276 $135 Million
Q3 2020 May 24, 2024	SELL	$3.26 - $4.73 $77,662 - $112,682	-23,823 Reduced 66.41%	12,051 $40.9 Million
Q3 2020 Jun 26, 2023	BUY	$3.26 - $4.73 $39,286 - $57,001	12,051 New	12,051 $40.9 Million
Q2 2020 May 24, 2024	BUY	$1.58 - $4.63 $56,680 - $166,096	35,874 New	35,874 $166 Million
Q2 2020 Jun 26, 2023	BUY	$1.58 - $4.63 $56,680 - $166,096	35,874 New	35,874 $166 Million
Q3 2019 Jul 12, 2023	BUY	$2.67 - $3.65 $87,271 - $119,303	32,686 New	32,686 $96.1 Million

Others Institutions Holding AFMD

# of Institutions

Shares Held

1.09M

Call Options Held

Put Options Held

View Full List

About Affimed N.V.

Ticker AFMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,339,008
Market Cap $185M
Description
Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in P...

More about AFMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account